We are live on
!
Find out more
Metagenomi Therapeutics
58 hedge funds and large institutions have $14.2M invested in Metagenomi Therapeutics in 2025 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 22 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
45% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 22
53% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 19
Holders
58
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$393K | |
| 2 | +$197K | |
| 3 | +$145K | |
| 4 |
JP Morgan Chase
New York
|
+$124K |
| 5 |
Man Group
London,
United Kingdom
|
+$107K |
Top Sellers
| 1 | -$1.4M | |
| 2 | -$349K | |
| 3 | -$194K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$191K |
| 5 |
Goldman Sachs
New York
|
-$161K |